Soluble thrombomodulin as predictor of incident coronary heart disease [7]

Lancet

Volumn 354, Issue 9190, 1999, Pages 1646-1647

  Salomaa, V ^a   Wu, K K ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR PROTEIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

COMPETITIVE INHIBITION; ENZYME ACTIVATION; FEMALE; FIBRINOLYSIS; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER; MALE; PRIORITY JOURNAL; SOLUBILITY;

EID: 0033530373     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77134-8     Document Type: Letter

References (5)

1. G Cella ML Randi Soluble thrombomodulin as predictor of incident coronary heart disease Lancet 354 1999 425
2. LI Mennen J Amiral L Guize Y Pujol PY Scarabin Soluble thrombomodulin as predictor of incident coronary heart disease Lancet 354 1999 425 426
3. MR Goldstein Soluble thrombomodulin as predictor of incident coronary heart disease Lancet 354 1999 426
4. V Salomaa C Matei N Aleksic Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study Lancet 353 1999 1729 1734
5. L Bajzar M Nesheim J Morser PB Tracey Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thombin-activable fibrinolysis inhibitor J Biol Chem 273 1998 2792 2798